Moreover, miR-503 functioned as a tumor suppressor in HCC by directly targeting cyclin D3 and E2F3 through Rb-E2F signaling pathway, suggesting that miR-503/E2F3 may act as helpful therapeutic targets for HCC therapy [48]. This evidence concerns the gene CCND3 and hepatocellular carcinoma.